This includes common phrases such as: Diabetic neuropathy Neuropathy secondary to diabetes Nerve damage due to diabetes If the provider does not specify whether it is mononeuropathy, polyneuropathy, or autonomic neuropathy, E11.40 is the correct choice Assign E11.41 when the record documents mononeuropathy associated with diabetes
Your provider will work with you to determine the most appropriate option(s) based on your symptoms, preferences, and medical history
Insulin blocks fat mobilization
Prospective Covariate Control: Designing adequately powered prospective longitudinal studies capable of testing whether baseline microbial signatures predict treatment outcomes while strictly controlling for diet, metformin use, and weight loss dynamics
There are currently no established safety data specifically addressing GLP-1 agonist use in active Crohn's disease, requiring thorough informed consent, close monitoring, and coordination between specialists
The solution may be simpler than you think: targeted prebiotic support that nourishes your microbiome from within